Institut Català de la Salut
[Atzert N] Department of Allergy and Clinical Immunology, Kinderspital Zurich, Zurich, Switzerland. [Gore C] Department of Paediatric Allergy, Imperial College Healthcare NHS Trust, London, UK. Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK. [Knibb RC] Institute of Health and Neurodevelopment, Aston University, Birmingham, UK. [Alviani C] Faculty of Medicine, University of Southampton, Southampton, UK. The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, UK. [Angier E] Primary Care and Population Sciences, University of Southampton, Southampton, UK. [Blumchen K] Department of Pediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology, Goethe University, Frankfurt am Main, Germany. [Garriga-Baraut T] Servei de Pneumologia, Fibrosi Quística i Al·lèrgia Pediàtrica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Grup d’Investigació “Creixement i Desenvolupament”, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-10-13T06:37:41Z
2025-10-13T06:37:41Z
2025-06
Allergy; Transition; Young adults
Al·lèrgia; Transició; Adults joves
Alergia; Transición; Adultos jóvenes
Background Adolescents and young adults (AYA) with asthma and allergies have unexpectedly high mortality and morbidity. A survey in 2019 amongst healthcare professionals (HCPs) in Europe highlighted significant gaps in transition care, which negatively impacts patients' outcomes. Since then, an evidence-based guideline and practical toolbox for effective transition of AYA with asthma and allergies have been published. Aims To assess HCPs' perspectives, practice and challenges on transition care for AYA with asthma and allergies, including the impact of the recent guideline, potential differences across countries and changes since 2019. Methods Cross-sectional online survey-based study. European HCP managing AYA with allergies and/or asthma were invited to participate in May–June 2023. Results 511 responses were collected. Amongst respondents, 60%–70% were familiar with the guideline and toolbox, and found them helpful. At least for selected patients, 50%–85% of respondents adhered to some guideline recommendations and initiatives/resources for transition care such as simplifying medication regimes, seeing AYA on their own or producing transition reports. We observed improvements compared to 2019 in areas such as prioritising transition, training, assessment of psychosocial issues and transition readiness, access to other HCP, transfer and post-transfer feedback systems. However, 20% of respondents had no transition process and around 50% had no transition-specific elements. Sixty percent found transition care ‘very’ or ‘moderately challenging’, with transition not being prioritised, time constraints and limited expertise on psychosocial issues as leading problems. Significant differences were observed in transition practice across countries. Conclusion Despite improvement in training and approach towards transition care, challenges and limitations persist in effectively implementing evidence-based guidelines. Raising greater awareness about the need for, and the positive impact of high-quality transition care amongst policy-makers, HCP, and patients/families remains a key priority to unlock resources for training and effective implementation at a national/international level.
This Task force report was supported by the EAACI under the EAACI Task force ‘Allergic diseases in adolescents and young people, towards better patient centred care’, year 2023.
Article
Published version
English
Asma - Tractament; Al·lèrgia - Tractament; Enquestes; Joves adults; Assistència sanitària; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Patient Care::Continuity of Patient Care::Transition to Adult Care; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires; DISEASES::Immune System Diseases::Hypersensitivity; DISEASES::Respiratory Tract Diseases::Bronchial Diseases::Asthma; NAMED GROUPS::Persons::Age Groups::Adult::Young Adult; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::asistencia al paciente::continuidad de la atención al paciente::tránsito a la atención adulta; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios; ENFERMEDADES::enfermedades del sistema inmune::hipersensibilidad; ENFERMEDADES::enfermedades respiratorias::enfermedades bronquiales::asma; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::adulto::adulto joven
Wiley
Allergy;80(6)
https://doi.org/10.1111/all.16603
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3440]